Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 21, 2008

View Archived Issues

Imiquimod with PTD or HPV vaccination tested for vulval intraepithelial neoplasia

New agents for cardiovascular disorders disclosed in recent patents

Novel agents for respiratory disorders claimed in recent patent literature

Recent GSK patent divulges new antipsychotic agents

Immune stimulatory antigen-loaded particles show promise as tumor vaccine strategy

Infinity initiates phase I clinical trial of hedgehog pathway inhibitor IPI-926

Ipsen completes acquisition of Tercica

Miraculins enters into license agreement with Mount Sinai Hospital

Philips and Celsion enter research agreement to develop new cancer treatment

Lpath initiates dosing in phase I clinical trial of iSONEP in AMD

Ardea initiates combination phase I/II study of RDEA-119 and Nexavar in advanced cancer

Ono acquires from Progenics exclusive Japanese rights to Relistor

Crucell and Aeras initiate phase I and II trials in Africa of AERAS-402 TB vaccine

Novo Nordisk reports results from LEAD phase IIIb study of liraglutide in type 2 diabetes

Patients enter phase I combination study of GRN-163L for multiple myeloma

Positive final phase II results for EndoTAG-1 in pancreatic cancer

Aridol approved in Switzerland

VX-770 results show improvements in FEV1 and CFTR protein function

R&D highlights from the UBS Global Life Sciences Conference in New York: Arena Pharmaceuticals

AstraZeneca submits Seroquel XR in Europe for generalized anxiety disorder

Basilea's Toctino approved in France for hand eczema

CeNeRx initiates phase II Tyrima trial in depression

New in vivo studies planned for RhuDex

Studies show anesthetic effect of PF-0713, evaluate mechanism of action

PYY-3-36 analogue AC-163954 demonstrates improved stability, antiobesity effects in rodents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...